Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Guardant Health Inc    GH

GUARDANT HEALTH INC

(GH)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/17/2019 05/20/2019 05/21/2019 05/22/2019 05/23/2019 Date
76.18(c) 78.27(c) 76.38(c) 71.5(c) 75.81 Last
644 261 1 096 419 934 801 1 187 399 4 684 310 Volume
-0.55% +2.74% -2.41% -6.39% +6.03% Change
More quotes
Financials (USD)
Sales 2019 148 M
EBIT 2019 -125 M
Net income 2019 -127 M
Debt 2019 -
Yield 2019 -
Sales 2020 212 M
EBIT 2020 -99,3 M
Net income 2020 -99,9 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales2019 44,9x
Capi. / Sales2020 31,4x
Capitalization 6 654 M
More Financials
Company
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage... 
More about the company
Surperformance© ratings of Guardant Health Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GUARDANT HEALTH INC
12:02aGUARDANT HEALTH : Announces Pricing of Public Offering of Common Stock
AQ
05/21GUARDANT HEALTH : Announces Proposed Public Offering of Common Stock
AQ
05/20Guardant Health, Inc. Announces Proposed Public Offering of Common Stock
GL
05/15Guardant Health to Present Precision Oncology Data Across the Continuum of Ca..
GL
05/13GUARDANT HEALTH : Announces Plans for Prospective Colorectal Cancer Screening St..
AQ
05/10Symantec and Wynn decline while Zillow and Guardant rise
AQ
05/09GUARDANT HEALTH : 1Q Earnings Snapshot
AQ
05/09GUARDANT HEALTH, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
05/09GUARDANT HEALTH : Reports First Quarter 2019 Financial Results and Raises 2019 R..
AQ
05/03Guardant Health to Present at the Bank of America Merrill Lynch 2019 Health C..
GL
More news
Sector news : Bio Diagnostics & Testing
05/21Global chemical firms urged to source responsibly after lethal China blast - ..
RE
05/15GILEAD SCIENCES : Novartis gets approval to sell Kymriah in Japan for $306,000
RE
05/13REGENERON PHARMACEUTICALS : Says FDA Approves Eylea Injection for All Diabetic R..
DJ
05/10PATRICK THOMAS : Biotech Industry Woos Talent With Top Pay -- WSJ
DJ
05/09PATRICK THOMAS : Biotech Is Place to Be for Top Salaries
DJ
More sector news : Bio Diagnostics & Testing
Chart GUARDANT HEALTH INC
Duration : Period :
Guardant Health Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH INC
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 84,8 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Helmy Eltoukhy Chief Executive Officer & Director
AmrAli H. Talasaz Chairman, President & Chief Operations Officer
Derek A. Bertocci CFO, Principal Financial & Accounting Officer
Richard B. Lanman Chief Medical Officer
Samir Kaul Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GUARDANT HEALTH INC90.21%6 654
GENSCRIPT BIOTECH CORP57.14%4 033
IOVANCE BIOTHERAPEUTICS INC87.91%2 001
INVITAE CORP--.--%1 655
CAREDX INC32.10%1 432
MIRACA HOLDINGS INC.5.43%1 316